Mast cells and angiogenesis

Microscopy Research and Technique

Volumn 60, Issue 1, 2003, Pages 64-69

  Hiromatsu, Yuji ^a   Toda, Shuji ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Growth factor; Mast cells; Subacute thyroiditis; Tumor growth

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; CELL SIGNALING; COLLAGEN; DISEASES; ENDOTHELIAL CELLS; MUSCULOSKELETAL SYSTEM; REPAIR; TUMORS;

ANGIOGENESIS; CELL FUNCTIONS; ENDOTHELIAL CELL PROLIFERATION; GROWTH FACTOR; INFLAMMATORY DISORDERS; MAST CELLS; RHEUMATOID ARTHRITIS; SUBACUTE THYROIDITIS; TISSUE REPAIR; TUMOR GROWTH;

STEM CELLS;

ACETYLSALICYLIC ACID; CHEMOKINE; CYTOKINE; EPIDERMAL GROWTH FACTOR; GLUCOCORTICOID; IBUPROFEN; INDOMETACIN; NEUTRALIZING ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; STEM CELL FACTOR; TRYPTASE; VASCULOTROPIN;

ANGIOGENESIS; CELL ACTIVATION; CELL ACTIVITY; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CHEMOTAXIS; CONNECTIVE TISSUE; DRUG ACTIVITY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; MAST CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OVULATION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SUBACUTE THYROIDITIS; TARGET CELL; TISSUE DISTRIBUTION; TISSUE REPAIR; TUMOR GROWTH; WOUND HEALING;

EID: 0037221692     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.10244     Document Type: Review

References (78)

1. Alam R, Kumar D, Anderson-Walters A, Forsythe PA. 1994. Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol 152:1298-1303.
2. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. 1995. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024-1028.
3. Augustin HG, Braun K, Telemenakis I, Modlich U, Kuhn W. 1995. Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am J Pathol 147:339-351.
4. Aust G, Hofmann A, Laue S, Rost A, Kohler T, Scherbaum WA. 1997. Human thyroid carcinoma cell lines and normal thyrocytes: Expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein. Thyroid 7:713-724.
5. Benitez-Bribiesca L, Wong A, Utrera D, Castellanos E. 2001. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem 49:1061-1062.
6. Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG, Gruber BL. 1997. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 99:2691-2700.
7. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. 1995. Heterogeneity of human mast cells based on cytokine content. J Immunol 155:297-307.
8. Brindley LL, Sweet JM, Goetzl EJ. 1983. Stimulation of histamine release from human basophils by human platelet factor 4. J Clin Invest 72:1218-1223.
9. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ, Dorf ME. 1989. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med. 170:245-257.
10. Dastych J, Metcalfe DD. 1994. Stem cell factor induces mast cell adhesion to fibronectin. J Immunol 152:213-219.
11. Donhuijsen K, Sastry M, Volker B, Leder LD. 1992. Mast cell frequency in soft tissue tumors: Relation to type and grade of malignancy. Pathol Res Pract 188:61-66.
12. Dumont JE, Lamy F, Roger P, Maenhaut C. 1992. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 72:667-697.
13. Duncan LM, Richards LA, Mihm MC Jr. 1998. Increased mast cell density in invasive melanoma. J Cutan Pathol 25:11-15.
14. Fang KC, Wolters PJ, Steinhoff M, Bidgol A, Blount JL, Caughey GH. 1999. Mast cell expression ofgelatinases A and B is regulated by kit ligand and TGF-beta. J Immunol 162:5528-5535.
15. Folkman J. 1990. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6.
16. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1:27-31.
17. Folkman J. 1996. Fighting cancer by attacking its blood supply. Sci Am 275:150-154.
18. Foreman JC. 1993. Non-immunological stimuli of mast cells and basophil leukocytes. In: Foreman JC, editor. Immunopharmacology of mast cells and basophils. New York: Academic. p 57-69.
19. Foschi D, Castoldi L, Corsi F, Radaelli E, Trabucchi E. 1994. Inhibition of inflammatory angiogenesis in rats by loco-regional administration of hydrocortisone and protamine. Agents Actions 42:40-43.
20. Gannon FH, Glaser D, Caron R, Thompson LD, Shore EM, Kaplan FS. 2001. Mast cell involvement in fibrodysplasia ossificans progressiva. Hum Pathol 32:842-848.
21. Gorski JP, Hugli TE, Muller-Eberhard HJ. 1979. C4a: The third anaphylatoxin of the human complement system. Proc Natl Acad Sci USA 76:5299-5302.
22. Gruber BL, Marchese MJ, Suzuki K, Schwartz LB, Okada Y, Nagase H, Ramamurthy NS. 1989. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest 84:1657-1662.
23. Gruber BL, Marchese MJ, Kew R. 1995. Angiogenic factors stimulate mast-cell migration. Blood 86:2488-2493.
24. Hawkins RA, Claman HN, Clark RA, Steigerwald JC. 1985. Increased dermal mast cell populations in progressive systemic sclerosis: A link in chronic fibrosis? Ann Intern Med 102:182-186.
25. Hugli TE, Muller-Eberhard HJ. 1978. Anaphylatoxins: C3A and C5a. Adv Immunol 26:1-53.
26. Hunt LW, Colby TV, Weiler DA, Sur S, Butterfield JH. 1992. Immunofluoreseent staining for mast cells in idiopathic pulmonary fibrosis: Quantification and evidence for extracellular release of mast cell tryptase. Mayo Clin Proc 67:941-948.
27. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ. 1994. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 144:321-328.
28. Imada A, Shijubo N, Kojima H, Abe S. 2000. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J 15:1087-1093.
29. Ionov ID. 1991. Inhibition of mast cell activity as a new approach to anti-cancer therapy. Int J Radiat Biol 60:287-291.
30. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS. 1999. Inhibition of angiogenesis by nonsteroidal antiinflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5:1418-1423.
31. Kahari VM, Saarialho-Kere U. 1997. Matrix metalloproteinases in skin. Exp Dermatol 6:199-213.
32. Kankkunen JP, Harvina IT, Naukkarinen A. 1997. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 72:385-388.
33. Koga M, Hiromatsu Y, Jimi A, Toda S, Koike N, Nonaka K. 1999. Immunohistochemical analysis of Bcl-2, Bax, and Bak expression in thyroid glands from patients with subacute thyroiditis. J Clin Endocrinol Metab 84:2221-2225.
34. Kuo CJ, Farnebo F, Yu EY, Christofferson R, Swearingen RA, Carter R, von Recum HA, Yuan J, Kamihara J, Flynn E, D'Amato R, Folkman J, Mulligan RC. 2001. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl Acad Sci USA 98:4605-4610.
35. Lachter J, Stein M, Lichtig C, Eidelman S, Munichor M. 1995. Mast cells in colorectal neoplasias and premalignant disorders. Dis Colon Rectum 38:290-293.
36. Lagunoff D, Martin TW, Read G. 1983. Agents that release histamine from mast cells Annu Rev Pharmacol Toxicol 23:331-351.
37. Levi-Schaffer F, Pe'er J. 2001. Mast cells and angiogenesis. Clin Exp Allergy 31:521-524.
38. Malone DG, Wilder RL, Saavedra-Delgado AM, Metcalfe DD. 1987. Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy. Arthritis Rheum 30:130-137.
39. Meininger CJ, Zetter BR. 1992. Mast cells and angiogenesis. Semin Cancer Biol 3:73-79.
40. Mekori YA, Oh CK, Metcalfe DD. 1993. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J Immunol 151:3775-3784.
41. Metcalfe DD, Baram D, Mekori YA. 1997. Mast cells. Physiol Rev 77:1033-1079.
42. Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS. 1991. Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J Exp Med 174:821-825.
43. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M. 1998. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 341:309-315.
44. Norrby K, Sorbo J. 1992. Heparin enhances angiogenesis by a systemic mode of action. Int J Exp Pathol 73:147-155.
45. Qu Z, Liebler JM, Powers MR, Galey T, Ahmadi P, Huang XN, Ansel JC, Butterfield JH, Planck SR, Rosenbaum JT. 1995. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 147:564-573.
46. Ribatti D, Vacca A, Marzullo A, Nico B, Ria R, Roncali L, Dammacco F. 2000. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int J Cancer 85:171-175.
47. Ribatti D, Crivellato E, Candussio L, Nico B, Vacca A, Roncali L, Dammacco F. 2001. Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin Exp Allergy 31:602-608.
48. Rioux KP, Sharkey KA, Wallace JL, Swain MG. 1996. Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis. Hepatology 23:888-895.
49. Risau W. 1997. Mechanisms of angiogenesis. Nature 386:671-674.
50. Risau W, Flamme I. 1995. Vasculogenesis. Annu Rev Cell Dev Biol 11:73-911.
51. Roche WR. 1986. The nature and significance of tumor-associated mast cells. J Pathol 148:175-182.
52. Rottem M, Barbieri S, Kinet JP, Metcalfe DD. 1992. Kinetics of the appearance of Fc epsilon RI-bearing cells in interleukin-3-dependent mouse bone marrow cultures: Correlation with histamine content and mast cell maturation. Blood 79:972-980.
53. Schleimer RP, Bochner BS. 1994. The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 94:1202-1213.
54. Schwartz LB. 1993. Heterogeneity of human mast cells. In: Kaliner MA, Metcalfe DD, editors. The Mast Cells in Health and Disease. New York: Dekker. p 219-236.
55. Selvan RS, Butterfield JH, Krangel MS. 1994. Expression of multiple chemokine genes by a human mast cell leukemia. J Biol Chem 269:13893-13898.
56. Sorbo J, Jakobsson A, Norrby K. 1994. Mast-cell histamine is angiogenic through receptors for histamine1 and histamine2. Int J Exp Pathol 75:43-50.
57. Starkey JR, Crowle PK, Taubenberger S. 1988. Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 42:48-52.
58. Subramanian N, Bray MA. 1987. Interleukin 1 release histamine from human basophils and mast cells in vitro. J Immunol 138:271-275.
59. Takanami I, Takeuchi K, Naruke M. 2000. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 88:2686-2692.
60. Takeda K, Hatamochi A, Ueki H. 1989. Increased number of mast cells accompany enhanced collagen synthesis in linear localized scleroderma. Arch Dermatol Res 281:288-290.
61. Taylor AM, Galli SJ, Coleman JW. 1995. Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: Dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents. Immunology 86:427-433.
62. εRI) during differentiation of mouse mast cells and human basophils. J Clin Invest 85:1227-1233.
63. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. 1991. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947-11954.
64. Toda S, Sugihara H. 1990. Reconstruction of thyroid follicles from isolated porcine follicle cells in three-dimensional collagen gel culture. Endocrinology 126:2027-2034.
65. Toda S, Nishimura T, Yamada S, Koike N, Yonemitsu N, Watanabe K, Matsumura S, Gartner R, Sugihara H. 1999. Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture. J Pathol 188:415-422.
66. Toda S, Tokuda Y, Koike N, Yonemitsu N, Watanabe K, Koike K, Fujitani N, Hiromatsu Y, Sugihara H. 2000. Growth factor-expressing mast cells accumulate at the thyroid tissue-regenerative site of subacute thyroiditis. Thyroid 10:381-386.
67. Toda S, Koike N, Sugihara H. 2001. Thyrocyte integration, and thyroid folliculogenesis and tissue regeneration: Perspective for thyroid tissue engineering. Pathol Int 51:403-417.
68. Tozzi CA, Thakker-Varia S, Yu SY, Bannett RF, Peng BW, Poiani GJ, Wilson FJ, Riley DJ. 1998. Mast cell collagenase correlates with regression of pulmonary vascular remodeling in the rat. Am J Respir Cell Mol Biol 18:497-510.
69. Trabucchi E, Radaelli E, Marazzi M, Foschi D, Musazzi M, Veronesi AM, Montorsi W. 1988. The role of mast cells in wound healing. Int J Tissue React 10:367-372.
70. Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC. 1992. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 80:374-381.
71. Unger EF, Sheffield CD, Epstein SE. 1991. Heparin promotes the formation of extracardiac to coronary anastomoses in a canine model. Am J Physiol 260 (Heart Circ Physiol 29): H1625-H1634.
72. Volpé R. 1995. Subacute thyroiditis. In: Ingbar SH, Braverman LE, editors. The Thyroid. Philadelphia: JB Lippincott. p 1106-1119.
73. White MV. 1993. Mast cell secretagogues. In: Kaliner MA, Metcalfe DD, editors. The Mast Cells in Health and Disease. New York: Dekker. p 109-128.
74. White MV, Yoshimura T, Hook W, Kaliner MA, Leonard EJ. 1989. Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release. Immunol Lett 22:151-154.
75. Wintroub BU, Schechter NB, Lazarus GS, Kaempfer CE, Schwartz LB. 1984. Angiotensin I conversion by human and rat chymotryptic proteinases. J Invest Dermatol 83:336-339.
76. Yamada T, Sawatsubashi M, Yakusbiji H, Itoh Y, Edakuni G, Mori M, Robert L, Miyazaki K. 1998. Localization of vascular endothelial growth factor in synovial membrane mast cells: Examination with "multi-labelling subtraction immunostaining." Virchows Arch 433:567-570.
77. Yamamoto T, Katayama I, Nishioka K. 1997. Expression of stem cell factor in basal cell carcinoma. Br J Dermatol 137:709-713.
78. Zhang W, Stoica G, Tasca SI, Kelly KA, Meininger CJ. 2000. Modulation of tumor angiogenesis by stem cell factor. Cancer Res 60:6757-6762.